Andere Sprachen Cosmos Health Inc.

Aktien

A3DZZN

US2214133058

COSM

Markt geschlossen - Nasdaq Andere Börsenplätze 22:00:00 21.06.2024			% 5 Tage	% 1. Jan.
0,6741 ^USD	-6,24 %		+2,15 %	-52,19 %

18.06.	Cosmos Health erwirbt alle Rechte an einem Patent zur Behandlung von Krebserkrankungen des zentralen Nervensystems	MT
21.03.	Cosmos Health Inc. beginnt mit der Entwicklung von Cloudscreen 2.0, der neuen Iteration seiner KI-Plattform für das Repurposing von Arzneimitteln der nächsten Generation	CI

Andere Sprachen

Erhalten Sie Zugang zu allen Nachrichten über alle Unternehmen: Verpassen Sie keine profitable Anlagechance mehr!

100% kostenlose Registrierung

Cosmos Health Strengthens Global Brain Tumor Market Position by Entering Agreement to Acquire Remaining Rights to WIPO-Filed CNS Cancer Drug Patent	19.06.
Cosmos Health to Acquire Full Rights to Patent Targeting Central Nervous System Cancers	18.06.
Cosmos Health Participated in Vitafoods Europe 2024, Receives Significant Interest and Numerous New Partnership Inquiries for its Sky Premium Life Nutraceuticals Brand	20.05.
Cosmos Health : Change in Certifying Accountants - Form 8-K	26.04.
Cosmos Health : RELATED PARTY TRANSACTION POLICIES AND PROCEDURES - Form 8-K	22.03.
Cosmos Health Inc. Commences Development of Cloudscreen 2.0 the New Iteration of Its Next Generation AI Drug Repurposing Platform	21.03.
Cosmos Health Inc. Receives Regulatory Approval to Sell Sky Premium Life Products in UAE Nutritional Supplements Market	18.03.
Cosmos Health Successfully Completes Acquisition of Pharmatrade's Assets, Expects to Increase FY 2024 Annual Revenue by over $5 Million	01.03.
Cosmos Health CEO, Greg Siokas, Purchases Shares in the Open Market, Showcasing His Confidence in the Company	21.02.
Cosmos Health Bolsters Presence in $400Bn+ Global Generic Drugs Market with $3.5M Acquisition of 10-Drug Portfolio	19.01.
Cosmos Health Acquires Rights to Patent for Drug Targeting Central Nervous System Cancers	07.12.
Cosmos Health Files Patent Application for Obesity, Weight Management Product With European Patent Office	01.12.
Tranche Update on Cosmos Health Inc.'s Equity Buyback Plan announced on January 24, 2023.	20.11.
Cosmos Health Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	20.11.
Cosmos Health Insider Bought Shares Worth $158,806, According to a Recent SEC Filing	12.10.23
Cosmos Health to Acquire Cloudscreen, a Cutting-Edge AI-Powered Drug Repurposing Platform, Anticipated to Establish Cosmos as a Leader in the $25Bn Global Market and Deliver Unparalleled Returns for Shareholders	12.10.23
Sector Update: Health Care Stocks Softer Late Afternoon	11.10.23
Sector Update: Health Care Stocks Drop Wednesday Afternoon	11.10.23
Cosmos Health Says it has Agreed to Buy Cloudscreen in a Cash-and-Stock Deal.	11.10.23
Cosmos Health Inc. has entered into a purchase agreement to acquire Cloudscreen.	11.10.23

Keine Ergebnisse zu dieser Suche

Alle Nachrichten Analystenempfehlungen Wichtige Fakten Insiders Transkripte Pressemitteilungen Offizielle Publikationen Andere Sprachen Trading-Ideen MarketScreener Artikel MarketScreener Analysen

Andere Sprachen Cosmos Health Inc.

Aktien

A3DZZN

US2214133058

COSM

Andere Sprachen

Filter